1. Home
  2. INTA vs RCUS Comparison

INTA vs RCUS Comparison

Compare INTA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intapp Inc.

INTA

Intapp Inc.

HOLD

Current Price

$48.02

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$18.65

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTA
RCUS
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.2B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
INTA
RCUS
Price
$48.02
$18.65
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
★ $41.57
$40.00
AVG Volume (30 Days)
474.8K
★ 1.9M
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $577,805,000.00
$247,000,000.00
Revenue This Year
$14.07
N/A
Revenue Next Year
$15.22
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.62
N/A
52 Week Low
$19.01
$17.43
52 Week High
$47.93
$31.74

Technical Indicators

Market Signals
Indicator
INTA
RCUS
Relative Strength Index (RSI) 80.94 28.06
Support Level $20.15 N/A
Resistance Level N/A $24.38
Average True Range (ATR) 1.60 1.68
MACD 0.94 -0.40
Stochastic Oscillator 98.44 16.87

Price Performance

Historical Comparison
INTA
RCUS

About INTA Intapp Inc.

Intapp Inc is a provider of AI-powered solutions for professional firms in regulated industries. Its vertically tailored solutions are purpose-built for the specialized workflows, complex relationship networks, and professional compliance requirements of accounting, consulting, investment banking, legal, private capital, and real assets firms. By applying Firm AI to core processes and data, Intapp helps partners, dealmakers, and advisors drive firm growth, manage compliance, and improve profitability. Its products include AI & Data Platform, Intapp Celeste and Firm AI, and Intapp Integration Service. The Company operates in accounting, consulting, corporate, investment banking and advisory, and other industries. The Company operates in the UK and the US, with maximum revenue from the US.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: